CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO
Netherlands Designer Drug Awards 2014 - Winners and Losers
A December 24, 2014, article in the online news site VICE highlights the latest novel psychoactive substance (NPSs) to emerge over the past year. In the article, the author awards titles to specific NPS drugs from categories such as psychedelics, stimulants, and benzodiazepines to synthetic cannabinoids and dissociative hallucinogens (The VICE Netherlands Designer Drug Awards 2014).
 
To compile the list (see below), the author consulted designer drug reviewers from the website Chemsrus, analyzed drug trends from Google Analytics®, and browsed different online drug forums. 
 
Winners:
  • Most innovative drug of 2014 — LSZ, a hallucinogen with similar sensory altering effects as LSD but with less duration.
  • Most obscure drug of 2014 — 5-DBFPV, a synthetic cathinone that has comparable euphoric effects to MDPV.
  • Fastest riser of 2014 — 3,4-CTMP, a stimulant that according to the authors was the most searched substance in a prominent online drug forum.
  • Newest drug of 2014 — 3-Fluorophenmetrazine (3-FPM), a stimulant that emerged online in November 2014.
Losers:
  • Biggest loser of 2014 — Empathogens (drugs like MDMA). According to the author, drugs such as 5-EAPB and 5-MAPB began to wane in popularity in 2014 after drug reviewers reported negative experiences.
Cerilliant's catalog of solution-based Certified Reference Materials (CRMs) is constantly being updated with CRMs of the latest novel psychoactive substances and their stable-labeled internal standards for amphetamine-type stimulants (ATSs), synthetic cannabinoids, designer benzodiazepines, synthetic cathinones, phenethylamines and synthetic analgesics and hallucinogens. These NPS standards are suitable for a variety of uses from forensic drug testing, clinical toxicology analysis, and calibrator preparation to urine drug testing, and isotope dilution methods.
 
Cerilliant's USDEA exemptions and TK#s allow laboratories in the US and Canada to order standards of controlled NPS drugs without additional regulatory paperwork. Click on the links below to view listings of NPS Certified Spiking Solutions®:
 
 
 
 


Return to Article List


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn